In December, the Office for Civil Rights (OCR), in coordination with the Substance Abuse and Mental Health Services Administration (SAMSA), issued a Notice of Proposed Rule Making (NPRM) that would modify the [...]
A recent Determination of Coverage provides that, under specific circumstances, the dispensing and prescribing of Naloxone to non-health center patients is protected by the Federal Tort Claims Act (FTCA) program. On August [...]
Last week, the Department of Justice (DOJ) announced the arrest of 60 individuals for allegedly participating in illegal prescribing and distributing opioids and other narcotics and for their participation in various health [...]
